PTGS2 and breast cancer: For this, we accessed the cancer therapeutics response portal v2 (CTRP v2) resulting from 37 breast cancer cell lines treated with the COX-2 selective inhibitor, valdecoxib (http://portals.broadinstitute.org/ctrp/).